VERRICA PHARMACEUTICALS INC. - COMMON STOCK

0.6634

07-February-25 16:45:00

15 minutes delayed

Stocks

-0.0203

-2.97%

Today's range

0.6630 - 0.6867

ISIN

N/A

Source

NASDAQ

Verrica Pharmaceuticals Announces Exclusive Licensing Agreement With Torii Pharmaceutical Co., Ltd. To Develop and Commercialize VP-102 For Molluscum and Common Warts in Japan

17 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results

04 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference

03 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
Verrica Pharmaceuticals Announces Participation in the Cowen 41st Annual Health Care Conference

23 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

17 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Conference

19 Jan 2021 07:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.